Effects of tumor necrosis factor-α on podocyte expression of monocyte chemoattractant protein-1 and in diabetic nephropathy

Nephron Extra

Volumn 5, Issue 1, 2015, Pages 1-18

  Chung, Choon Hee ^a,b   Fan, Jingyi ^a,d   Lee, Eun Young ^a,c   Kang, Jeong Suk ^c   Lee, Seung Joo ^c   Pyagay, Petr E ^a   Khoury, Charbel C ^a   Yeo, Tet Kin ^a   Khayat, Mark F ^a   Wang, Amy ^a   Chen, Sheldon ^a,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Yonsei University Wonju   (South Korea)

^c Soonchunhyang University   (South Korea)

^d WUHAN UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Akt or protein kinase B; Albuminuria; Diabetic rodent model; Nuclear factor kappaB; Phosphatidylinositol 3 kinase; TNF receptor 2

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84934294088     PISSN: None     EISSN: 16645529     Source Type: Journal    
DOI: 10.1159/000369576     Document Type: Article

References (48)

1. Nakamura T, Fukui M, Ebihara I., Osada S, Nagaoka I, Tomino Y., Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993; 42: 450-456.
2. Sugimoto H, Shikata K, Wada J., Horiuchi S, Makino H: Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overex-pression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 1999; 42: 878-886.
3. Mensah-Brown E.P., Obineche EN, Galadari S, Chandranath E., Shahin A, Ahmed I, Patel S.M., Adem A: Strepto-zotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines. Cytokine 2005; 31: 180-190.
4. Navarro JF, Mora C, Muros M., Garcia J: Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Nephrol Dial Transplant 2006; 21: 3428-3434.
5. Moriwaki Y, Inokuchi T, Yamamoto A., Ka T, Tsutsumi Z, Takahashi S., Yamamoto T: Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats. Acta Diabetol 2007; 44: 215-218.
6. Chan LY, Leung JC, Tsang A.W., Tang SC, Lai KN: Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int 2005; 67: 602-612.
7. Jevnikar AM, Brennan DC, Singer G.G., Heng JE, Maslinski W, Wuthrich RP, Glimcher L.H., Kelley VE: Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha. Kidney Int 1991; 40: 203-211.
8. Dong X, Swaminathan S, Bachman L.A., Croatt AJ, Nath KA, Griffin MD: Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 2007; 71: 619-628.
9. Lai KN, Leung JC, Chan L.Y., Saleem MA, Mathieson PW, Lai FM, Tang SC: Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 2008; 294:F945-F955.
10. Awad AS, Rouse MD, Khutsishvili K, Huang L., Bolton WK, Lynch KR, Okusa MD: Chronic sphingosine 1-phos-phate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int 2011; 79: 1090-1098.
11. Fornoni A, Ijaz A, Tejada T., Lenz O: Role of inflammation in diabetic nephropathy. Curr Diabetes Rev 2008; 4: 10-17.
12. Navarro-Gonzalez J.F., Mora-Fernandez C: The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-442.
13. Ohta MY, Nagai Y, Takamura T., Nohara E, Kobayashi K: Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells. Metabolism 2000; 49: 163-166.
14. Tesch GH: MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 2008; 294:F697-F701.
15. Ruster C, Wolf G: The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 2008; 13: 944-955.
16. Tarabra E, Giunti S, Barutta F., Salvidio G, Burt D, Deferrari G., Gambino R, Vergola D, Pinach S, Perin PC, Camussi G, Gruden G: Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 2009; 58: 2109-2118.
17. Lee EY, Chung CH, Khoury C.C., Yeo TK, Pyagay PE, Wang A, Chen S: The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 2009; 297:F85-F94.
18. Navarro JF, Milena FJ, Mora C, Leon C., Claverie F, Flores C, Garcia J: Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Kidney Int Suppl 2005;S98-S102.
19. Lee EY, Chung CH, Kim J.H., Joung HJ, Hong SY: Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes. Nephrol Dial Transplant 2006; 21: 1496-1503.
20. Chen S, Kasama Y, Lee J.S., Jim B., Marin M, Ziyadeh FN: Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. Diabetes 2004; 53: 2939-2949.
21. Sung SH, Ziyadeh FN, Wang A, Pyagay P.E., Kanwar YS, Chen S: Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 2006; 17: 3093-3104.
22. Wang A, Ziyadeh FN, Lee E.Y., Pyagay PE, Sung SH, Sheardown SA, Laping N.J., Chen S: Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol 2007; 293:F1657-F1665.
23. Berridge MV, Herst PM, Tan AS: Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005; 11: 127-152.
24. Rao VH, Meehan DT, Delimont D, Nakajima M., Wada T, Gratton MA, Cosgrove D: Role for macrophage metal-loelastase in glomerular basement membrane damage associated with alport syndrome. Am J Pathol 2006; 169: 32-46.
25. Doublier S, Lupia E, Catanuto P., Periera-Simon S, Xia X, Korach K., Berho M, Elliot SJ, Karl M: Testosterone and 17beta-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice. Kidney Int 2011; 79: 404-413.
26. Rosa AC, Rattazzi L, Miglio G., Collino M, Fantozzi R: Angiotensin II induces tumor necrosis factor-alpha expression and release from cultured human podocytes. Inflamm Res 2012; 61: 311-317.
27. Bruggeman LA, Drawz PE, Kahoud N, Lin K., Barisoni L, Nelson PJ: TNFR2 interposes the proliferative and NF-kappaB-mediated inflammatory response by podocytes to TNF-alpha. Lab Invest 2011; 91: 413-425.
28. Hoffmann U, Bergler T, Rihm M., Pace C, Kruger B, Rummele P., Stoelcker B, Banas B, Mannel DN, Kramer BK: Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant 2009; 9: 675-686.
29. Ueda A, Okuda K, Ohno S., Shirai A, Igarashi T, Matsunaga K., Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T: NF-kappaB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153: 2052-2063.
30. Gruden G, Setti G, Hayward A., Sugden D, Duggan S, Burt D., Buckingham RE, Gnudi L, Viberti G: Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol 2005; 16: 688-696.
31. Gohda T, Niewczas MA, Ficociello L.H., Walker WH, Skupien J, Rosetti F, Cullere X., Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS: Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 2012; 23: 516-524.
32. Niewczas MA, Gohda T, Skupien J., Smiles AM, Walker WH, Rosetti F, Cullere X., Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS: Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 2012;23:507-515.
33. Omote K, Gohda T, Murakoshi M., Sasaki Y, Kazuno S, Fujimura T., Ishizaka M, Sonoda Y, Tomino Y: Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice. Am J Physiol Renal Physiol 2014; 306:F1335-F1347.
34. Palladino MA, Bahjat FR, Theodorakis E.A., Moldawer LL: Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2003; 2: 736-746.
35. Grund EM, Kagan D, Tran C.A., Zeitvogel A., Starzinski-Powitz A, Nataraja S, Palmer SS: Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells. Mol Pharmacol 2008; 73: 1394-1404.
36. Bian ZM, Elner SG, Yoshida A, Elner VM: Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. Invest Ophthalmol Vis Sci 2004; 45: 1887-1896.
37. Pincheira R, Castro AF, Ozes O.N., Idumalla PS, Donner DB: Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J Immunol 2008; 181: 1288-1298.
38. Noiri E, Kuwata S, Nosaka K., Tokunaga K, Juji T, Shibata Y., Kurokawa K: Tumor necrosis factor-alpha mRNA expression in lipopolysaccharide-stimulated rat kidney. Chronological analysis of localization. Am J Pathol 1994; 144: 1159-1166.
39. Gao G, Zhang B, Ramesh G., Betterly D, Tadagavadi RK, Wang W, Reeves WB: TNF-alpha mediates increased susceptibility to ischemic AKI in diabetes. Am J Physiol Renal Physiol 2013; 304:F515-F521.
40. Liu J, Zhao Z, Willcox M.D., Xu B., Shi B: Multiplex bead analysis of urinary cytokines of type 2 diabetic patients with normo- and microalbuminuria. J Immunoassay Immunochem 2010; 31: 279-289.
41. Ristola M, Arpiainen S, Saleem M.A., Holthofer H., Lehtonen S: Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF-kappaB and silenced by DNA methylation. Nephrol Dial Transplant 2012; 27: 1737-1745.
42. Yamauchi K, Takano Y, Kasai A., Hayakawa K, Hiramatsu N, Enomoto N., Yao J, Kitamura M: Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes. Kidney Int 2006; 70: 892-900.
43. Kalantarinia K, Awad AS, Siragy HM: Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int 2003;64: 1208-1213.
44. Chow FY, Nikolic-Paterson DJ, Ozols E., Atkins RC, Rollin BJ, Tesch GH: Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int 2006; 69: 73-80.
45. Awad AS, Kinsey GR, Khutsishvili K, Gao T., Bolton WK, Okusa MD: Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am J Physiol Renal Physiol 2011; 301:F1358-F1366.
46. Chow FY, Nikolic-Paterson DJ, Atkins R.C., Tesch GH: Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 2004; 19: 2987-2996.
47. Burt D, Salvidio G, Tarabra E., Barutta F, Pinach S, Dentelli P., Camussi G, Perin PC, Gruden G: The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes. Am J Pathol 2007; 171: 1789-1799.
48. Setti G, Hayward A, Dessapt C., Barone F, Buckingham R, White K., Bilous R, Hiroshi K, Gruden G, Viberti G, Gnudi L: Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone prevents albuminuria but not glomerulosclerosis in experimental diabetes. Am J Nephrol 2010; 32: 393-402.